-
ALBO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Albireo Pharma (ALBO)
Company Profile
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 272.48 mm | 272.48 mm | 272.48 mm | 272.48 mm | 272.48 mm | 272.48 mm |
Cash burn (monthly) | (no burn) | (no burn) | 12.60 mm | 10.78 mm | 9.88 mm | 9.61 mm |
Cash used (since last report) | n/a | n/a | 337.69 mm | 288.80 mm | 264.70 mm | 257.56 mm |
Cash remaining | n/a | n/a | -65.21 mm | -16.33 mm | 7.78 mm | 14.92 mm |
Runway (months of cash) | n/a | n/a | -5.2 | -1.5 | 0.8 | 1.6 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 44.48 mm |
Total shares | 1.41 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Ics Opportunities | 999.36 k | $43.73 mm |
Tang Capital Partners | 411.97 k | $0.00 |
Huntington National Bank | 1.00 | $744.00 k |
Proequities | 0.00 | $0.00 |